TOPDDRIVE Trademark
Trademark Overview
On Tuesday, October 14, 2025, a trademark application was filed for TOPDDRIVE with the United States Patent and Trademark Office. The USPTO has given the TOPDDRIVE trademark a serial number of 99442152. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 5, 2026. This trademark is owned by Callio Operating Co, Inc.. The TOPDDRIVE trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials
Custom manufacturing of pharmaceuticals and therapeutic agents for medical use
Pharmaceutical and biological preparations for the treatment of cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology
General Information
| Serial Number | 99442152 |
| Word Mark | TOPDDRIVE |
| Filing Date | Tuesday, October 14, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, May 5, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 5, 2026 |
Trademark Statements
| Goods and Services | Research and development in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology; Providing medical scientific research information in the fields of pharmaceuticals, biologics, chemistry, protein engineering, proteins and derivatives, antibody-drug conjugates, immunostimulatory anti-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies, oncology, and immunology; Drug discovery, custom design, and development services featuring therapeutic agents for the treatment and prevention of diseases; Scientific investigations for medical purposes featuring clinical trials |
| Pseudo Mark | TOP D DRIVE |
| Goods and Services | Custom manufacturing of pharmaceuticals and therapeutic agents for medical use |
| Goods and Services | Pharmaceutical and biological preparations for the treatment of cancer; Pharmaceuticals and biological preparations for prophylactic, diagnostic, and therapeutic use in treating, preventing, and managing cancer; Therapeutic agents for medical use, namely, proteins and derivatives, antibody-drug conjugates, immunostimulatory antibody-drug conjugates, antibodies with multiple drug or cytokine conjugates, multispecific antibodies, and engineered antibodies; Pharmaceutical and biological preparations for the prevention, diagnosis and treatment of diseases for scientific, clinical, medicinal, therapeutic and diagnostic purposes; Pharmaceutical and biological preparations for use in oncology |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 14, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 14, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 14, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Callio Operating Co, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98101
US |
| Party Name | Callio Operating Co, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98101
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 14, 2025 | NEW APPLICATION ENTERED |
| Tuesday, October 14, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 11, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 3, 2026 | ASSIGNED TO EXAMINER |
| Friday, March 20, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, March 20, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, March 20, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 7, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, April 7, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 7, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 8, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 29, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 5, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 5, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
